“I thought I would never live to see the end of that day,” said Mount Sinai Beth Israel patient Robert Cohen, recollecting his experience as a young U.S. infantryman landing on Utah Beach on June 6, 1944. Mr. Cohen spent the 70th anniversary of the D-Day landing with Alene, his wife of 66 years, his son Michael, two of his eight grandchildren, and Mount Sinai Beth Israel staff, discussing the events of that day, when he was one of 20,000 Allied troops landing at Utah Beach, the westernmost flank of the Normandy invasion.
A novel vaccine that stimulates the body’s immune response has been effective in shrinking tumors in patients with low-grade, B-cell lymphoma. Two patients enrolled in a clinical trial at The Tisch Cancer Institute at the Mount Sinai Health System experienced partial remissions of their disease within six months after completing treatment.
The federal Centers for Medicare and Medicaid Services (CMS) has awarded $9.6 million to Icahn School of Medicine at Mount Sinai to establish a Mobile Acute Care Team (MACT) program that provides patients with eligible medical conditions the same level of acute care they would receive in the hospital, but in their home environment.
Peter Palese, PhD, a world-renowned microbiologist who has led seminal studies that continue to greatly expand the understanding of influenza viruses, was recently named a member of the 2014 class of the American Academy of Arts and Sciences. The organization is one of the nation’s most acclaimed honorary societies and a leading center for independent policy research. It includes among its current members more than 250 Nobel Laureates across disciplines and more than 60 Pulitzer Prize winners.
The Office for Diversity and Inclusion invites all Mount Sinai Health System employees, family members, and friends to march with Mount Sinai in the New York City Pride Parade. RSVP at http://tiny.cc/SinaiPrideParade2014.
Mount Sinai marchers must register to receive specific event details, including meeting time and locations.
The graduation marked the end of a 16-week program for 22 comadronas (birth attendants) enrolled in the school of POWHER (Providing Outreach in Women’s Health Education and Resources). The school is funded by Saving Mothers, a 501c3 nonprofit dedicated to reducing maternal mortality and morbidity, for which Dr. Shirazian is the co-founder and Medical Director.
A commitment to excellence in clinical practice and patient satisfaction were central themes at six Town Hall meetings in April and May, when leaders from the Mount Sinai Health System met with faculty and staff from each hospital to discuss the institution’s strategic direction and answer questions about its integration.
The meetings—which included question-and-answer sessions—summed up the progress that has been made since The Mount Sinai Medical Center combined with Continuum Health Partners last fall.
There are more than 42 million adolescents between the ages of 10-19 in the United States. Worldwide one in six people is a teenager. As recently noted by the World Health Organization, “Promoting healthy practices during adolescence, and taking steps to better protect young people from health risks are critical for the prevention of health problems in adulthood, and for countries’ future health and social infrastructure.” In other words, if we want to keep our communities healthy, teen health is essential.
Since the mid-20th century, the health field has recognized the unique needs of adolescents and their right to developmentally appropriate services that openly address the health and behavioral realities of teen life. Today, adolescent medicine is an established field as a sub-specialty of pediatrics. MDs with training in pediatrics, family medicine, or internal medicine can enter adolescent medicine fellowship programs.
Melanoma is the deadliest and most preventable skin disease. It is a skin cancer arising from melanocytes, skin cells that carry pigment also know as melanin, which gives skin its color. Melanocytes are the cells that also form benign (non-cancerous) moles known as nevi. The distinction between harmless moles and potentially deadly melanoma can be challenging even for the most experienced dermatologists.